aTYR PHARMA INC
ATYR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001339970
No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding aTYR PHARMA INC changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 56 | 47 | −9 |
| Shares | 41.8M | 48.1M | +6.32M (+15.1%) |
| Value | $81.5M | $75.1M | −$6.44M (−7.9%) |
New holders (8)
Institutions that held aTYR PHARMA INC at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $1.56M | 0.00% |
| Superstring Capital Management LP | 313,028 | $488.3K | 0.62% |
| Sanctuary Advisors, LLC | 29,207 | $45.9K | 0.00% |
| Virtu Financial LLC | 27,966 | $44.0K | 0.00% |
| Verition Fund Management LLC | 12,675 | $19.8K | 0.00% |
| Cypress Capital, LLC | 200 | $312 | 0.00% |
| Sachetta, LLC | 150 | $297 | 0.00% |
| Strategic Investment Solutions, Inc. | 8 | $16 | 0.00% |
Sold out (17)
Institutions that held aTYR PHARMA INC at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Octagon Capital Advisors LP | 700,000 | $1.36M |
| Barclays PLC | 604,299 | $1.18M |
| Goldman Sachs Group Inc | 217,233 | $423.6K |
| Marshall Wace, LLP | 158,619 | $309.3K |
| Pale Fire Capital SE | 91,232 | $177.9K |
| XTX Topco Ltd | 83,328 | $162.5K |
| Citigroup Inc | 78,620 | $153.3K |
| Kingswood Wealth Advisors, LLC | 60,000 | $117.0K |
| Jump Financial, LLC | 49,904 | $97.3K |
| Acadian Asset Management LLC | 45,366 | $87.0K |
| Y-Intercept (Hong Kong) Ltd | 43,892 | $85.6K |
| SG Americas Securities, LLC | 28,256 | $55.0K |
| UBS Group AG | 20,192 | $39.4K |
| CTC Alternative Strategies, Ltd. | 17,600 | $34.3K |
| Two Sigma Securities, LLC | 17,487 | $34.1K |
| Prudential Financial Inc | 16,000 | $31.2K |
| Two Sigma Investments, LP | 10,088 | $19.7K |